Feature Channels: Cardiovascular Health

• share
• favorite_border

In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults, more than half of all adults, are eligible for semagludtide for weight loss, diabetes management, or prevention of recurrent cardiovascular events.

• share
• favorite_border

UChicago Medicine's current clinic on Salt Creek Lane in Hinsdale will close Nov. 21, and open across the street in a new, larger facility Dec. 2.

• share
• favorite_border

Attend The Society of Thoracic Surgeons’ 2025 Annual Meeting, featuring late-breaking scientific research, thought-provoking lectures, cutting-edge technologies, and innovative cardiothoracic surgery products, January 24 – January 26, in Los Angeles.

• share
• favorite_border

Newly updated stroke prevention guidelines from the American Heart Association and American Stroke Association say women with endometriosis and women with early-onset menopause are at greater risk.

• share
• favorite_border

Recycled pacemakers can function as well as new devices, a University of Michigan-led study suggests. These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and middle-income countries, where many patients cannot afford the treatment.

• share
• favorite_border

On June 13, Bonnie Hutton became the first patient in Kentucky to receive a GORE TAMBE device. Since then, Sam Tyagi, M.D., a vascular surgeon at UK HealthCare, said they’ve already been able to complete four such surgeries with several more already scheduled.

• share
• favorite_border

Researchers at Children’s Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene therapy trial for Danon disease (DD), a rare, X-linked heart condition caused by a single gene mutation. The phase 1 trial was a collaboration between CHOP and the University of California, San Diego Medical Center, the University of Colorado, Anschutz Medical Center, Boston Children's Hospital and Rocket Pharmaceuticals. The data on the results of the RP-A501 Phase 1 trial, presented at a late breaking session today at the American Heart Association Scientific Sessions 2024 in Chicago, were also published in the New England Journal of Medicine.

• share
• favorite_border

Alcohol-related deaths in the U.S. nearly doubled from 1999 to 2020. The sharpest spike occurred among 25–34-year-olds (nearly fourfold), while individuals aged 55–64 had the highest rates. Men consistently had higher rates but women saw the largest proportional rise, with deaths increasing 2.5 times. Asian and Pacific Islander communities experienced the steepest ethnic increase, while the Midwest saw the greatest regional rise (2.5 times), followed by the Northeast, West, and South.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Cedars-Sinai has published a summary highlighting its research advances for November 2024.

• share
• favorite_border

Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center are the only New Jersey hospitals to achieve the Extracorporeal Life Support Organization’s (ELSO) Gold Level Center of Excellence in Life Support Award.

• share
• favorite_border

Alyssa Stolarik, RN, BSN, clinical coordinator of Cardiology at Hackensack Meridian Health Mountainside Medical Center, received the Second Best Research Poster Award at the American College of Cardiology (ACC) Quality Summit held in San Antonio, Texas. Her work, titled “Improving Compliance with Post-PCI Creatinine,” highlights significant advancements in the management of post-procedural care and patient outcomes. The research addresses the critical issue of acute kidney injury (AKI) post-percutaneous coronary intervention (PCI), demonstrating a marked reduction in risk-standardized AKI rates, which significantly surpasses national benchmarks.

• share
• favorite_border

A new editorial – published in Nature – suggests that frequent fluctuations in diet, commonly known as "yo-yo dieting," can significantly increase the risk of cardiovascular disease. The authors, from the University of Pennsylvania Schools of Nursing and Medicine, describe how cycling between high-fat and low-fat diets in mice led to a substantial acceleration of atherosclerosis, a condition characterized by the buildup of plaque in arteries.

• share
• favorite_border

Un estudio de Mayo Clinic sugiere que un estent en forma de reloj de arena podría mejorar el flujo sanguíneo y aliviar el dolor torácico intenso y recurrente en personas con microangiopatía.

• share
• favorite_border

Um estudo da Mayo Clinic sugere que um stent em forma de ampulheta poderia melhorar o fluxo sanguíneo e aliviar a dor torácica intensa e recorrente em pessoas com microangiopatia.

• share
• favorite_border

Jiang He, M.D., Ph.D., Professor and Chair Designate of Epidemiology in the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center, is a 2024 recipient of the American Heart Association’s (AHA) highest commendation, the Distinguished Scientist award. The honor recognizes Dr. He’s prolific research on reducing the risks of cardiometabolic diseases, including heart disease, stroke, obesity, Type 2 diabetes, hypertension, dyslipidemia, and chronic kidney disease.